|
Post by sellhighdrinklow on Aug 9, 2019 23:27:16 GMT -5
|
|
|
Post by winner on Aug 10, 2019 6:07:16 GMT -5
Good morning one and all Please excuse me if I am breaking a forum rule but in case somebody missed a post authored by longliner on the 2nd Aug at 4:34 P.M.. See excerpt directly below ------------------------------------------------------------------------------------------------ Interesting (to me) Dexcom instagram shown by solicurance on ST, Technosphere inhaler is in the add?? Don't hit me with that fly swatter Liane. Read more: mnkd.proboards.com/thread/6109/mnkd-on-stocktwits?page=34#ixzz5wC9pAaxz------------------------------------------------------------------------------------------------ Stay tuned for future developments...
|
|
|
Post by akemp3000 on Aug 10, 2019 6:48:38 GMT -5
Really great and interesting video. Dexcom's G7 in early 2020 will be another big step forward. The only thing missing is a drug that actually works in tandem with a CGM to greatly improve diabetics time-in-range...hmmm
|
|
|
Post by sportsrancho on Aug 10, 2019 8:19:12 GMT -5
Good morning one and all Please excuse me if I am breaking a forum rule but in case somebody missed a post authored by longliner on the 2nd Aug at 4:34 P.M.. See excerpt directly below ------------------------------------------------------------------------------------------------ Interesting (to me) Dexcom instagram shown by solicurance on ST, Technosphere inhaler is in the add?? Don't hit me with that fly swatter Liane. Read more: mnkd.proboards.com/thread/6109/mnkd-on-stocktwits?page=34#ixzz5wC9pAaxz------------------------------------------------------------------------------------------------ Stay tuned for future developments...
|
|
|
Post by peppy on Aug 10, 2019 8:22:51 GMT -5
Good morning one and all Please excuse me if I am breaking a forum rule but in case somebody missed a post authored by longliner on the 2nd Aug at 4:34 P.M.. See excerpt directly below ------------------------------------------------------------------------------------------------ Interesting (to me) Dexcom instagram shown by solicurance on ST, Technosphere inhaler is in the add?? Don't hit me with that fly swatter Liane. Read more: mnkd.proboards.com/thread/6109/mnkd-on-stocktwits?page=34#ixzz5wC9pAaxz------------------------------------------------------------------------------------------------ Stay tuned for future developments... The continuous Glucose monitor will save afrezza. We are not blind, we can see. When the graph shows up on the iPhone, the better. Thanks for posting the picture sports. This would be a useful post on the united health group site.
|
|
|
Post by Clement on Aug 10, 2019 8:37:45 GMT -5
What's the lag time between a sensor reading of glucose in interstitial fluid and the actual value of glucose in the bloodstream? From an old article: "Sensor levels may trail glucose levels by 5–10 min during periods of rapid change" www.ncbi.nlm.nih.gov/pmc/articles/PMC2903977/This has implications of how fast a loop might appear to be responding versus the reality.
|
|
|
Post by goyocafe on Aug 10, 2019 8:49:24 GMT -5
The continuous Glucose monitor will save afrezza. We are not blind, we can see. When the graph shows up on the iPhone, the better. Thanks for posting the picture sports. This would be a useful post on the united health group site. It’s a curious photo to me to see OneDrop included with Dexcom except for one thing; the expanded coaching service and accompanying database of customers that Dachi’s company has amassed over the past few years. I can see a Google type company taking an agnostic approach to device and drug integration with a more holistic objective of providing a best in class connected health care service. That said, they would ultimately choose drugs and devices that offer the best outcomes for its patients.
|
|
|
Post by bioexec25 on Aug 10, 2019 8:56:41 GMT -5
|
|
paul
Researcher
Posts: 134
|
Post by paul on Aug 10, 2019 9:24:27 GMT -5
I fast forwarded since I didn't see anything particularly interesting. About all I got new from the video was that Apple was making an app to send data from the Dexcom CGM to the watch. Was there anything I missed to suggest afrezza involvement?
|
|
|
Post by goyocafe on Aug 10, 2019 9:26:14 GMT -5
I fast forwarded since I didn't see anything particularly interesting. About all I got new from the video was that Apple was making an app to send data from the Dexcom CGM to the watch. Was there anything I missed to suggest afrezza involvement? A picture is worth a thousand words. I think it’s a lot like panning for gold, lots of little bits to collect, but they add up over time. The photo on Instagram was posted by Dexcom, yet it shows a OneDrop glucose meter and an Afrezza inhaler. Dexcom is working with Google/Verily on the G7, but Google is not just interested in device development, they’re a data/information company and hence the dots begin to look like they line up. It’s speculation, but that’s what panning for gold is, too.
|
|
paul
Researcher
Posts: 134
|
Post by paul on Aug 10, 2019 9:29:21 GMT -5
What picture?
|
|
|
Post by goyocafe on Aug 10, 2019 9:31:45 GMT -5
|
|
|
Post by peppy on Aug 10, 2019 9:50:08 GMT -5
I fast forwarded since I didn't see anything particularly interesting. About all I got new from the video was that Apple was making an app to send data from the Dexcom CGM to the watch. Was there anything I missed to suggest afrezza involvement?No. This was user involvement the way I see it. Demand. (in a sense) Where and when Afrezza becomes involved is the control the diabetic can have over their blood glucose level with this information. When afrezza users learn how to dose, their blood glucose levels can be superior. My understanding, (failed understanding) is that after drugs/medications are approved by the FDA the real world experience should count. The CGM gives us visual real world data. Afrezza: 12 minutes to first measurable effect, 35 mins to peak effect, 90 mins to baseline for a 4 unit. Those are pretty safe parameters. and it shows in the graph. Fiasp: 20 mins. 90 mins 5 hours. .1 unit/kg. The graphs will show this piece of chit as well.
|
|
|
Post by markado on Aug 10, 2019 10:28:32 GMT -5
I think MR from UTHR said it well, when she indicated Technosphere was the dosing platform of the (near) future - of course for Afrezza and TechT, but also as a platform for many meds. Likely for convenience, improved efficacy and on-set and reduced risk to liver, kidneys and digestive track due to orals. The tech companies understand platforms very well, and their variable viability to perform in multiple functions/applications. If these players can operate jointly to change and monitor dosage delivery for better outcomes for diabetes, they'll look to explore the next most addressable major disease states thereafter. Anything that boosts the uptake/prescription rate for Afrezza, boosts the viability and visibility of Technosphere, and that's good for all MNKD.
|
|
|
Post by goyocafe on Aug 10, 2019 11:32:22 GMT -5
The continuous Glucose monitor will save afrezza. We are not blind, we can see. When the graph shows up on the iPhone, the better. Thanks for posting the picture sports. This would be a useful post on the united health group site. It’s a curious photo to me to see OneDrop included with Dexcom except for one thing; the expanded coaching service and accompanying database of customers that Dachi’s company has amassed over the past few years. I can see a Google type company taking an agnostic approach to device and drug integration with a more holistic objective of providing a best in class connected health care service. That said, they would ultimately choose drugs and devices that offer the best outcomes for its patients. I think this photo actually originated from an Instagram user named @mjaimerd2be and is given credit for it by @dexcomwarriors. @dexcom looks like a locked or unused account. Not sure who is behind @dexcomwarriors. There are a number of photos on @mjaimerd2be's page with references to Afrezza. Worth a look. www.instagram.com/mjaimerd2be/
|
|